Copyright
©The Author(s) 2023.
World J Gastroenterol. May 21, 2023; 29(19): 3003-3012
Published online May 21, 2023. doi: 10.3748/wjg.v29.i19.3003
Published online May 21, 2023. doi: 10.3748/wjg.v29.i19.3003
Table 3 Factors associated with the targeted antiviral effects (hepatitis B viral deoxyribonucleic acid at delivery < 2 × 105)
Variable | Univariate | P value | Multivariate | P value |
Age (yr, continuous) | 1.034 (0.85-1.26) | 0.745 | 0.727 | |
BMI (kg/m2, continuous) | 1.18 (0.95-1.47) | 0.146 | 0.071 | |
25(OH) D3 (ng/mL, continuous) | 1.16 (1.03-1.31) | 0.014 | 1.23 (1.04-1.44) | 0.026 |
VDR Cdx2 TT | 0.2 (0.036-1.097) | 0.064 | 0.09 (0.01-0.88) | 0.039 |
Maternal GGT at delivery | 0.94 (0.86-1.006) | 0.075 | 0.05 | |
Maternal VD at delivery (ng/mL, continuous) | 1.1 (0.999-1.21) | 0.053 | 0.385 | |
Maternal alkaline phosphatase at delivery | 0.98 (0.96-1.002) | 0.081 | 0.64 | |
Maternal cholesterol at delivery | 0.47 (0.26-0.86) | 0.015 | 0.39 (0.17-0.87) | 0.021 |
- Citation: Wang R, Zhu X, Zhang X, Liu H, Ji YL, Chen YH. Association of vitamin D and polymorphisms of its receptor with antiviral therapy in pregnant women with hepatitis B. World J Gastroenterol 2023; 29(19): 3003-3012
- URL: https://www.wjgnet.com/1007-9327/full/v29/i19/3003.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i19.3003